• LAST PRICE
    31.4000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    29.0000/ 1
  • Ask / Lots
    34.0000/ 7
  • Open / Previous Close
    0.0000 / 31.4000
  • Day Range
    ---
  • 52 Week Range
    Low 13.2500
    High 48.2900
  • Volume
    7
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table
TimeVolumeRGC
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesRGC
Regencell Bioscience Holdings Ltd
424.1M
-85.9x
---
United StatesPHAT
Phathom Pharmaceuticals Inc
383.9M
-2.3x
---
United StatesCYDY
Cytodyn Inc
382.9M
-1.3x
---
United StatesTCRT
Alaunos Therapeutics Inc
464.8M
-6.7x
---
United StatesMLTX
MoonLake Immunotherapeutics
387.4M
-5.8x
---
United StatesOCGN
Ocugen Inc
379.0M
-5.9x
---
As of 2022-10-05

Company Information

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Contact Information

Headquarters
11/F First Commercial Building 33-35 Leighton Roa, Hong Kong 999077
Phone
---
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$424.1M
Revenue (TTM)
$0.00
Shares Outstanding
13.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.37
Book Value
$-0.32
P/E Ratio
-85.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.